A Correction to this paper has been published: https://doi.org/10.1038/s42255-021-00397-5.
Correction to: Nature Metabolism https://doi.org/10.1038/s42255-021-00366-y, published online 12 April 2021.
In the version of this article initially published, affiliations 3 and 4 were switched; the correct affiliations are 3NGM Biopharmaceuticals, South San Francisco, CA, USA and 4Alnylam Pharmaceuticals, Inc., Cambridge, MA, USA. In addition, the colors in Fig. 5k were rendered in greyscale in the published version. Finally, a middle initial has been added for author Harding H. Luan. The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Weng, JH., Koch, P.D., Luan, H.H. et al. Publisher Correction: Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nat Metab 3, 728 (2021). https://doi.org/10.1038/s42255-021-00397-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-021-00397-5
